This site is intended for healthcare professionals
News

Phase III FIDELIO-DKD study of BAY 94 8862 shows benefits in chronic kidney disease + T2D.- Bayer

Read time: 1 mins
Last updated:26th Oct 2020
Published:25th Oct 2020
Condition: Diabetes Type 2 and Kidney Disease
Type: drug
Register free for full access to medthority.com